Robert W. Baird initiated coverage on Ocular Therapeutix with a new price target

4/21/23 7:41:49 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Robert W. Baird initiated coverage of Ocular Therapeutix with a rating of Outperform and set a new price target of $18.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OCUL

Date	Price Target	Rating	Analyst
4/8/2025		Outperform	William Blair
3/18/2025	$17.00	Outperform	RBC Capital Mkts
3/11/2025	$15.00	Buy	Needham
10/16/2024		Sector Outperform	Scotiabank
6/20/2024	$7.00 → $11.00	Hold → Buy	TD Cowen
5/31/2024	$15.00	Overweight	Piper Sandler
2/9/2024	$15.00	Buy	BofA Securities
4/21/2023	$18.00	Outperform	Robert W. Baird